Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

348
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
348
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

246
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
246
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

148
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
148
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

249
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
249
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

186
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
186
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

858
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
858

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individualized Therapy Guided by Drug Susceptibility Testing for Multidrug-Resistant Tuberculosis.

Open forum infectious diseases·2026
Same author

Global prevalence and determinants of hospital-acquired COVID-19: protocol for a systematic review and meta-analysis.

BMJ open·2026
Same author

Treatment outcomes and long-term relapse-free survival after multidrug-resistant tuberculosis treatment in Latvia: a retrospective national cohort study.

The Lancet regional health. Europe·2026
Same author

Host- and pathogen-related determinants of pulmonary <i>versus</i> extrapulmonary tuberculosis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Noninvasive diagnosis of pulmonary tuberculosis using face mask sampling: a prospective study in adults.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025
Same author

Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort study.

The Journal of infection·2025
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

Related Experiment Video

Updated: Jul 15, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

[Extrapulmonary tuberculosis].

Thomas Theo Brehm, Elena Terhalle

    Deutsche Medizinische Wochenschrift (1946)
    |October 4, 2023
    PubMed
    Summary
    This summary is machine-generated.

    Extrapulmonary tuberculosis (TB) is challenging to diagnose and treat due to varied symptoms. Early recognition and effective management by healthcare providers are crucial for better patient outcomes.

    More Related Videos

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
    08:10

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

    Published on: April 9, 2012

    80.8K
    Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
    09:54

    Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

    Published on: February 16, 2020

    5.8K

    Related Experiment Videos

    Last Updated: Jul 15, 2025

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
    10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    18.9K
    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
    08:10

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

    Published on: April 9, 2012

    80.8K
    Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
    09:54

    Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

    Published on: February 16, 2020

    5.8K

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Pulmonology

    Context:

    • Extrapulmonary tuberculosis (TB) involves sites beyond the lungs, presenting diagnostic and therapeutic complexities.
    • Manifestations are diverse and often non-specific, complicating early identification.
    • Commonly affected sites include lymph nodes, pleura, skin, CNS, and genitourinary system.

    Purpose:

    • To highlight the diagnostic and therapeutic challenges of extrapulmonary TB.
    • To emphasize the importance of clinical suspicion, imaging, histopathology, and microbiology in diagnosis.
    • To stress the need for increased healthcare provider awareness for timely management.

    Summary:

    • Extrapulmonary TB diagnosis relies on a multi-faceted approach combining clinical, imaging, histopathological, and microbiological data.
    • Treatment principles mirror pulmonary TB but require adjusted duration based on disease site and extent.
    • Effective management hinges on prompt recognition and awareness among medical professionals.

    Impact:

    • Improved diagnostic strategies for extrapulmonary TB.
    • Optimized treatment protocols tailored to specific disease sites.
    • Enhanced clinical awareness leading to earlier and more effective patient management.